# Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors

> **NCT07040969** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **West China Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Radiation-induced Oral Mucositis

## Interventions

- **DRUG:** Spray of spirulina derivatives
- **DRUG:** Spray of placebo
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT07040969
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-27
- **Primary completion:** 2026-01-15
- **Final completion:** 2026-04-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040969, "Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07040969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*